
A recent report entitled «Next generation thiazolyl ketone inhibitors of cytosolic phospholipase A2α for targeted cancer therapy», published in the prestigious journal Nature Communications, describes the development of novel inhibitors of the enzyme phospholipase A2 as a targeted therapy for cancer, in…